AMA submission on the Transparency Bill regulating pharmaceutical company and doctor relationships
The AMA has made the following submission to the Senate Inquiry into the Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013.
The AMA has made the following submission to the Senate Inquiry into the Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013.